Description
Glucagon (19-29) is also known as miniglucagon, an endogenous short peptide co-released with glucagon. Miniglucagon inhibits insulin secretion from pancreatic β-cells in a Ca2+-dependent manner.
Product Unit Size | Cost | Quantity | Stock |
---|
Glucagon (19-29) is also known as miniglucagon, an endogenous short peptide co-released with glucagon. Miniglucagon inhibits insulin secretion from pancreatic β-cells in a Ca2+-dependent manner.
Cas No. | 64790-15-4 |
---|---|
Purity | ≥95% |
Formula | C61H89N15O18S |
Formula Wt. | 1352.54 |
IUPAC Name | (3S)-4-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[ (2S)-4-amino-1-[[(1S,2S)-1-carboxy-2-hydroxypropyl]amino]-1, 4-dioxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4- methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino] -1, 5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3- phenylpropan-2-yl]amino]-3-[[(2S)-5-amino-2-[[(2S)-2-aminopropanoyl] amino]-5-oxopentanoyl]amino]-4-oxobutanoic acid |
Synonym | Des(1-18) glucagon, Miniglucagon |
Solubility | Soluble in water, DMSO. |
Appearance | White to off white powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Bataille D, Fontés G, Costes S, et al. The glucagon-miniglucagon interplay: a new level in the metabolic regulation. Ann N Y Acad Sci. 2006 Jul;1070:161-6. PMID: 16888159.
Dalle S, Fontés G, Lajoix AD, et al. Miniglucagon (glucagon 19-29): a novel regulator of the pancreatic islet physiology. Diabetes. 2002 Feb;51(2):406-12. PMID: 11812748.
Dalle S, Smith P, Blache P, et al. Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway. J Biol Chem. 1999 Apr 16;274(16):10869-76. PMID: 10196164.
Ethisterone derivative, synthetic steroid, used...
Non-proteinogenic amino acid, L-arginine metabo...
Triazole; 14-α demethylase inhibitor, potentia...
BK/SK, Kv1, Kv3, TASK-2 K+ channel blocker, vol...
NO donor.
PORCN inhibitor.
Thiazolidinedione; PPARγ agonist.
Fluoroquinolone; topoisomerase IV and bacterial...
Reversible DNMT1-selective inhibitor
Curcumin derivative; DNMT1 and α-amylase inhib...
Actinomycin derivative used to study apoptosis ...
Oltipraz analog, salivary gland secretion enhan...
D2/3 antagonist, hERG K+ channel blocker.
ROCK inhibitor.
TRPA1 agonist, xanthine oxidase inhibitor.
Inhibitor of PTEFb/CDK9.
Apoptosis inducing agent.
Fluoroquinolone; topoisomerase IV and bacterial...
Cyclosporin metabolite; formyl peptide inhibito...
Terpene alcohol found in spearmint oil; TRPV3 a...